Late-Stage Diversification of HIV-1 Protease Inhibitor via SuFEx Click Chemistry
Synthesis · 2026-11 · 58 (21) · 2512-2518
DOI: 10.1055/a-2930-3820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, online erschienen am 19.08.2026. Verfasst von Bipin Khanal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, New Mexico State University, Las Cruces, New Mexico, 88003, USA. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
The global HIV/AIDS epidemic continues to demand durable antiretroviral therapies. HIV-1 protease (HIV-PR) remains a central target, and although darunavir (DRV) exhibits exceptional resilience, resistance evolution necessitates continued innovation. Building on DRV’s success, structural modifications at key positions have yielded promising derivatives. In this work, we report the design and synthesis of over 20 DRV derivatives incorporating pyrazole and amino acid motifs at the P2′ position. These substituents were introduced to strengthen interactions within the protease active site and expand opportunities for resistance coverage. Sulfur(VI) fluoride exchange (SuFEx) chemistry was employed as a robust late-stage diversification strategy, enabling efficient coupling and rapid library generation. This approach highlights the potential to access structurally diverse HIV-1 protease inhibitors, laying the groundwork for the development of next-generation therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, New Mexico State University, Las Cruces, New Mexico, 88003, USA.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Khanal, B., Yamanushkin, P., & Gold, B. (2026). Late-Stage Diversification of HIV-1 Protease Inhibitor via SuFEx Click Chemistry. Synthesis, 58(21), 2512-2518. https://doi.org/10.1055/a-2930-3820
Vancouver
Khanal B, Yamanushkin P, Gold B. Late-Stage Diversification of HIV-1 Protease Inhibitor via SuFEx Click Chemistry. Synthesis. 2026;58(21):2512-2518. doi:10.1055/a-2930-3820
BibTeX
@article{Khanal2026,
author = {Khanal, Bipin and Yamanushkin, Pavel and Gold, Brian},
title = {Late-Stage Diversification of HIV-1 Protease Inhibitor via SuFEx Click Chemistry},
journal = {Synthesis},
year = {2026},
volume = {58},
number = {21},
pages = {2512--2518},
doi = {10.1055/a-2930-3820}
}
EUVIMED